Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Whitehouse Labs has expanded impurity testing capacity in its Lebanon, NJ, facility with the addition of an Agilent 7900 ICP-MS (inductively coupled plasma mass spectrophotometer) system.
read more
Whitehouse Laboratories has expanded its drug delivery device testing capabilities to encompass the full series of ISO 80369 standard test procedures.
read more
Wednesday, December 14, 2016
Whitehouse Laboratories, a division of AMRI, announced the addition of Disinfectant Efficacy testing capability to its Microbiology Laboratory. Clients will now have the opportunity to test their disinfectants for effectiveness based on AOAC and USP ...
read more
Wednesday, December 16, 2015
AMRI has acquired all the outstanding equity interests of Whitehouse Laboratories, a provider of testing services that includes chemical and material analysis, method development and validation and quality control verification services to the ...
read more
Friday, November 04, 2022
Wheeler Bio and CRB announced the start of construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM).
read more
Thursday, October 05, 2023
Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, announced the grand opening of their state-of-the-art drug substance Current Good Manufacturing Practices (CGMP) facility inside the Ziggurat...
read more
Thursday, December 01, 2022
Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-expressed protein therapeutics, announced it has been granted a license to ATUM’s proprietary Leap-In Transposase...
read more
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round.
read more
Wheeler Bio announced the appointment of Rajesh Beri, Ph.D., as Chief Development Officer.
read more
Thursday, January 06, 2022
Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round.
read more
Friday, February 15, 2019
West Pharmaceutical Services and Swissfillon AG have commenced discussions that are intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customers using West’s proprietary SmartDose drug delivery platform ...
read more
Thursday, October 11, 2018
West Pharmaceutical Services has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award.
read more
West Pharmaceutical Services filed a Worker Adjustment and Retraining Notification with the Indiana Department of Workforce Development informing the agency that it will to close the company’s Frankfort, Indiana contract manufacturing facility.
read more
Monday, February 04, 2019
West Pharmaceutical is recalling the Vial2Bag fluid transfer systems due to the possibility that the device may not adequately transfer concentrated medication from a vial to an IV bag before infusion into a patient's vein.
read more
West Pharmaceutical Services has expanded its presence in the Asia Pacific region with a new sales office in Korea—West Pharmaceutical Services Korea Ltd.
read more